Our analysis revealed that HAMP upregulation-associated worse survival outcomes were diminished in ccRCC patients who showed an intratumoral enrichment of natural killer (NK) cells, T Helper cells (TH1/2), and mesenchymal stem cells (Figure 5). Here, HAMP is linked to nonpapillary renal cell carcinoma.